disease-specific indices in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated

disease-specific indices in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated

Anti-MDA5-antibody-positive DM is characterised by amyopathic illness with quickly progressive and deadly ILD

Melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (DM) shows distinctive cutaneous and pathologic options. We describe two circumstances of myositis-associated quickly progressive interstitial lung illness (RP-ILD).

The sufferers had been two ladies from Kerala, India. Each sufferers had anti-MDA5 antibody-positive myositis. Each sufferers introduced with RP-ILD with none medical options of myositis and succumbed to their sickness regardless of aggressive medical remedy. Anti-MDA5-antibody-positive DM is characterised by amyopathic illness with quickly progressive and deadly ILD.

Serum alarmin ranges and disease-specific indices in sufferers with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) 

Background/goal: We evaluated the connection between serum alarmin ranges and disease-specific indices in sufferers with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Sufferers and strategies: Sera and information from 79 sufferers had been utilized. For AAV-specific indices, Birmingham vasculitis exercise rating (BVAS), five-factor rating (FFS), and vasculitis harm index (VDI) had been collected and serum ranges of 4 alarmins (hepatoma-derived development issue, excessive mobility group field protein 1, S100A9, and S100A12) had been measured utilizing enzyme-linked immunosorbent assay. Associations between alarmin ranges, AAV-specific indices, and inflammatory laboratory markers had been assessed.

Outcomes: S100A9 ranges had been considerably correlated with C-reactive protein ranges (r=0.316, p=0.005) and S100A12 ranges correlated with VDI (r=0.232, p=0.040), which was constant in a subgroup of sufferers with myeloperoxidase (perinuclear)-ANCA positivity. No different associations had been discovered between alarmin ranges and BVAS, FFS, and VDI.

Conclusion: The serum S100A12 degree was related to organ harm in AAV, particularly in myeloperoxidase (perinuclear)-ANCA-positive sufferers.

Enzyme-linked immunosorbent assay (ELISA) and coronavirus antigen microarray (COVAM) evaluation mapped antibody epitope 

Efficient strategies for predicting COVID-19 illness trajectories are urgently wanted. Right here, enzyme-linked immunosorbent assay (ELISA) and coronavirus antigen microarray (COVAM) evaluation mapped antibody epitopes within the plasma of COVID-19 sufferers (n = 86) experiencing a variety of illness states.

The experiments recognized antibodies to a 21-residue epitope from nucleocapsid (termed Ep9) related to extreme illness, together with admission to the intensive care unit (ICU), requirement for ventilators, or dying.

Importantly, anti-Ep9 antibodies will be detected inside 6 days post-symptom onset and typically inside 1 day. Moreover, anti-Ep9 antibodies correlate with numerous comorbidities and hallmarks of immune hyperactivity.

We introduce a simple-to-calculate, illness threat issue rating to quantitate every affected person’s comorbidities and age. For sufferers with anti-Ep9 antibodies, scores above 3.Zero predict extra extreme illness outcomes with a 13.42 probability ratio (96.7% specificity).

The outcomes lay the groundwork for a brand new kind of COVID-19 prognostic to permit early identification and triage of high-risk sufferers. Such data may information simpler therapeutic intervention.

IMPORTANCE The COVID-19 pandemic has resulted in over two million deaths worldwide. Regardless of efforts to struggle the virus, the illness continues to overwhelm hospitals with severely unwell sufferers.

Prognosis of COVID-19 is instantly completed by way of a mess of dependable testing platforms; nonetheless, prognostic prediction stays elusive. To this finish, we recognized a brief epitope from the SARS-CoV-2 nucleocapsid protein and likewise a illness threat issue rating primarily based upon comorbidities and age. The presence of antibodies particularly binding to this epitope plus a rating cutoff can predict extreme COVID-19 outcomes with 96.7% specificity.

cuttingimagehistology
cuttingimagehistology

Anti-IGF-IIR antibody

STJ96634 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IIR.

Anti-IGF-IR antibody

STJ93647 200 µl
EUR 236.4
Description: IGF-IR is a protein encoded by the IGF1R gene which is approximately 154,7 kDa. IGF-IR is localised to the cell membrane. It is involved in apoptotic pathways, the GPCR pathway and ERK signalling. It is a receptor tyrosine kinase which mediates actions of insulin-like growth factor 1. The activated protein is involved in cell growth and survival control and is also crucial for tumour transformation and survival of malignant cells. It is formed from two subunits, each of which is comprised of an extracellular alpha-subunit and a transmembrane beta-subunit with intracellular tyrosine kinase activity. IGF-IR is expressed in the nervous system, skin, pancreas, lung and muscle. Mutations in the IGF1R gene may result in insulin-like growth factor 1 resistance. STJ93647 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of IGF-IR protein.

Anti-IGF-IR antibody

STJ93648 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IR.

Anti-IGF-I antibody

STJ93653 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-I.

Anti-IGF-IIR antibody

STJ93654 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IIR.

Anti-IGF-IIR antibody

STJ93655 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IIR.

Anti-IGF-IR antibody

STJ93656 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IR.

Anti-IGF-IR antibody

STJ93657 200 µl
EUR 236.4
Description: Rabbit polyclonal to IGF-IR.

Anti-IGF-IR antibody

STJ98158 100 µl
EUR 280.8
Description: Mouse monoclonal to IGF-IR.

Anti-IGF-IR antibody

STJ98159 100 µl
EUR 280.8
Description: Mouse monoclonal to IGF-IR.

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 336

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 336

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 336

Human Salivary IGF(salivary IGF) ELISA Kit

QY-E05383 96T
EUR 433.2

IGF-1, Human

HY-P7018 10ug
EUR 129.6

IGF-2, Human

HY-P7019 100ug
EUR 432

IGF-BP3, Human

HY-P7020 10ug
EUR 280.8

IGF-BP5, Human

HY-P7021 50ug
EUR 721.2

IGF-1, human

RC216-12 1mg
EUR 451.5

IGF-BP3, human

RC216-12B3 5ug
EUR 125.26

Anti-Rat IGF-1 Antibody

5121-100
EUR 379.2

Anti-Rat IGF-1 Antibody

5121-30T
EUR 175.2

anti-IGF-1R (Ab-1280)

LF-PA20229 100 ul
EUR 400.8
Description: Rabbit polyclonal to IGF-1R

anti-IGF-1R (Ab-1346)

LF-PA20230 100 ul
EUR 400.8
Description: Rabbit polyclonal to IGF-1R

anti-IGF-1R (Ab-1161)

LF-PA20231 100 ul
EUR 400.8
Description: Rabbit polyclonal to IGF-1R

anti-IGF-1R (Phospho-Tyr1161)

LF-PA20233 100 ul
EUR 424.8
Description: Rabbit polyclonal to IGF-1R (Phospho-Tyr1161)

Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody

A2160-100 100 µg
EUR 612

IGF-II

PR15045CF 50 ug
EUR 333.6

Human [Ala31] IGF-I

AIU020 20 µg
EUR 303.6

Human [Ala31] IGF-I

AIU100 100 µg
EUR 415.2

IGF-BP2, human recombinant

7165-10
EUR 301.2

IGF-BP2, human recombinant

7165-50
EUR 1123.2

IGF-BP7, human recombinant

7167-10
EUR 248.4

IGF-BP7, human recombinant

7167-50
EUR 810

IGF-BP6, human recombinant

7350-20
EUR 444

IGF-BP1, human recombinant

4717-100
EUR 744

IGF-BP1, human recombinant

4717-1000
EUR 3778.8

IGF-BP1, human recombinant

4717-25
EUR 307.2

IGF-BP3, human recombinant

4720-100
EUR 744

IGF-BP3, human recombinant

4720-1000
EUR 3778.8

IGF-BP3, human recombinant

4720-25
EUR 307.2

IGF-BP5, human recombinant

4723-100
EUR 744

IGF-BP5, human recombinant

4723-1000
EUR 3778.8

IGF-BP5, human recombinant

4723-25
EUR 307.2

IGF-I, human recombinant

4119-100
EUR 210

IGF-I, human recombinant

4119-1000
EUR 411.6

IGF-I, human recombinant

4119-10MG
EUR 1834.8

IGF-I, human recombinant

4119-1G
EUR 49388.4

IGF-I, human recombinant

4119-20MG
EUR 2793.6

IGF-I, human recombinant

4119-5000
EUR 1149.6

IGF-I, human recombinant

4119-50MG
EUR 5064

IGF-II, human recombinant

4122-10
EUR 164.4

IGF-II, human recombinant

4122-1000
EUR 1886.4

IGF-II, human recombinant

4122-50
EUR 307.2

Human [Leu60] IGF-I

ABU020 20 µg
EUR 303.6

Human [Leu60] IGF-I

ABU100 100 µg
EUR 415.2

Human IGF-I Protein

abx060791-100ug 100 ug
EUR 560.4

Biotinyl Human IGF-I

AQU010 10 µg
EUR 303.6

Biotinyl Human IGF-I

AQU050 50 µg
EUR 415.2

Biotinyl Human IGF-I

AQU100 100 µg
EUR 637.2

Biotinyl Human IGF-I

AQU500 500 µg
EUR 1305.6

IGF-1, human recombinant

P1016-.02 20 µg
EUR 309.6
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue

IGF-1, human recombinant

P1016-.1 100 µg
EUR 915.6
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue

IGF-II, human recombinant

P1017-.01 10 µg
EUR 193.2
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family.

IGF-II, human recombinant

P1017-.05 50 µg
EUR 375.6
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family.

IGF-II, human recombinant

P1017-1 1 mg
EUR 2397.6
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family.

rec IGF-I (human)

H-5555.0050 50.0µg
EUR 290.4
Description: CAS# [67763-96-6]

rec IGF-I (human)

H-5555.0100 100.0µg
EUR 457.2
Description: CAS# [67763-96-6]

rec IGF-I (human)

H-5555.0500 0.5mg
EUR 1720.8
Description: CAS# [67763-96-6]

Human [Arg6] IGF-II

GU020 20 µg
EUR 303.6

Human IGF-1 LR3

SP-89927-100 100 ug
EUR 270

Human [Leu24] IGF-I

ZU020 20 µg
EUR 303.6

Human [Leu24] IGF-I

ZU100 100 µg
EUR 415.2

Human [Leu27]IGF-II

TU100 100 µg
EUR 415.2

Anti-IGF-1R (Ab-1161) Antibody

A00070-1 100ul
EUR 476.4
Description: Rabbit Polyclonal IGF-1R (Ab-1161) Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

Polyclonal Anti-Rat IGF-1 Antibody

APR00269G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Anti-Rat IGF-1 . This antibody is tested and proven to work in the following applications:

anti-IGF-1R (Ab-1165/1166)

LF-PA20232 100 ul
EUR 400.8
Description: Rabbit polyclonal to IGF-1R

anti-IGF-1R (Phospho-Tyr1165/Tyr1166)

LF-PA20234 100 ul
EUR 424.8
Description: Rabbit polyclonal to IGF-1R (Phospho-Tyr1165/Tyr1166)

Anti-Phospho-IGF-IR (Y1161) antibody

STJ90298 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1161).

Anti-Phospho-IGF-IIR (S2409) antibody

STJ90923 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-IGF-IIR (S2409).

Anti-Phospho-IGF-IR (Y1161) antibody

STJ91026 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1161).

Anti-Phospho-IGF-IR (Y1346) antibody

STJ91187 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1346).

IGF-2/ Rat IGF- 2 ELISA Kit

ELA-E0051r 96 Tests
EUR 1063.2

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-100ug

QP8601-ec-100ug 100ug
EUR 489.6

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-10ug

QP8601-ec-10ug 10ug
EUR 240

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-1mg

QP8601-ec-1mg 1mg
EUR 1958.4

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-200ug

QP8601-ec-200ug 200ug
EUR 760.8

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-500ug

QP8601-ec-500ug 500ug
EUR 1272

Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-50ug

QP8601-ec-50ug 50ug
EUR 315.6

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-100ug

QP5264-100ug 100ug
EUR 435.6

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-10ug

QP5264-10ug 10ug
EUR 163.2

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-1mg

QP5264-1mg 1mg
EUR 1513.2

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-500ug

QP5264-500ug 500ug
EUR 914.4

Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-50ug

QP5264-50ug 50ug
EUR 284.4

Mouse Anti-Human IGF-1R monoclonal antibody, clone JID716

CABT-L2807-100uL500uL 100 uL, 500 uL
EUR 602.4

Anti-IGF1/Igf I Rabbit Monoclonal Antibody

M00148 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal IGF1/Igf I Antibody. Validated in WB and tested in Human.

Anti-IGF2/Igf Ii Rabbit Monoclonal Antibody

M00335 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal IGF2/Igf Ii Antibody. Validated in IF, WB and tested in Human.

Anti-Phospho-IGF-IR (Y1165/Y1166) antibody

STJ90299 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1165/Y1166).

Human IGF-I (Receptor Grade)

CM001 1 mg
EUR 1082.4

Human IGF-I (Receptor Grade)

CM005 5 mg
EUR 195.6

Human IGF-I (Receptor Grade)

CU020 20 µg
EUR 303.6

Human IGF-I (Receptor Grade)

CU100 100 µg
EUR 415.2

Human [Leu24] [Ala31] IGF-I

ADU020 20 µg
EUR 303.6

Human [Ala31] [Leu60] IGF-I

ALU020 20 µg
EUR 303.6

Human [Ala31] [Leu60] IGF-I

ALU100 100 µg
EUR 415.2

Human IGF-II (Receptor Grade)

FM001 1 mg
EUR 193.2

Human IGF-2 ELISA Kit

EHI0307 96Tests
EUR 625.2

R³ IGF-1, human recombinant

4216-100
EUR 196.8

R³ IGF-1, human recombinant

4216-1G
EUR 48018

R³ IGF-1, human recombinant

4216-1MG
EUR 385.2

Amount and High quality of tetanus antigen current in these merchandise is of utmost significance for product security and medical impact

Batch launch testing for human and veterinary tetanus vaccines nonetheless depends closely on strategies that contain animals, significantly for efficiency testing. The amount and high quality of tetanus antigen current in these merchandise is of utmost significance for product security and medical impact. Immunochemical strategies that measure consistency of antigen content material and high quality, doubtlessly as an indicator of efficiency, might be a better option and negate the necessity for an in vivo efficiency take a look at.

These immunochemical strategies require no less than one properly characterised monoclonal antibody (mAb) that’s particular for the goal antigen. On this paper we report the outcomes of the excellent characterisation of a panel of mAbs in opposition to tetanus with a view to pick out antibodies that can be utilized for improvement of an in vitro efficiency immunoassay.

Now we have assessed binding of the antibodies to native antigen (toxin), detoxified antigen (toxoid), adsorbed antigen and heat-altered antigen. Antibody operate was decided utilizing an in-house cell-based neutralisation assay to help prior in vivo efficiency information that was out there for some, however not all, of the antibodies.

As well as, antibody affinity was measured, and epitope competitors evaluation was carried out to establish pairs of antibodies that might be deployed in a sandwich immunoassay format. Not all characterisation checks offered proof of “superiority” of 1 mAb over one other, however collectively the outcomes from all characterisation research allowed for choice of an antibody pair to be taken ahead to assay improvement.

retrospectively analyzed the medical information of three anti-GAD65 antibody-positive sufferers to discover the variety and medical options of anti-GAD65 antibody-associated

Background: Antibodies in opposition to glutamic acid decarboxylase (GAD) are related to numerous neurologic circumstances described in sufferers, together with stiff individual syndrome, cerebellar ataxia, refractory epilepsy, and limbic and extralimbic encephalitis.

There have been some case reviews and investigations relating to anti-GAD65 antibody-associated encephalitis in grownup populations, however pediatric circumstances are uncommon. We retrospectively analyzed the medical information of three anti-GAD65 antibody-positive sufferers to discover the variety and medical options of anti-GAD65 antibody-associated pediatric autoimmune encephalitis.

Strategies: The medical information of a sequence of three sufferers optimistic for anti-GAD65 antibody had been retrospectively analyzed. GAD65 antibodies had been decided in serum and CSF utilizing a cell-based assay.

Outcomes: All three sufferers had been feminine, and the onset ages had been four years and 9 months, 6 years, and 16 years outdated. Their medical phenotypes included autoimmune limbic encephalitis, extralimbic encephalitis, and encephalitis combining limbic and extralimbic encephalitis. The medical signs included seizures, reminiscence deficits, drowsiness, dysautonomia, and headache. All sufferers had irregular carinal MRI and EEG.

All sufferers acquired immunotherapy and had transiently good responsiveness, however one affected person then skilled relapse. In follow-up, one affected person with extralimbic encephalitis recovered fully, whereas two sufferers with limbic involvement had poor outcomes with refractory focal epilepsy.

Conclusion: Along with limbic encephalitis, extralimbic encephalitis can be an necessary phenotype in sufferers who’re optimistic for anti-GAD65 antibodies. Early analysis and immunotherapy can enhance the signs. Nonetheless, sufferers with limbic encephalitis typically have refractory epilepsy within the continual part and have a poor long-term end result.

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 336

CXCL7 ELISA KIT|Human

EF001450 96 Tests
EUR 826.8

Human CXCL7 ELISA Kit

LF-EK50893 1×96T
EUR 777.6

NAP-2/CXCL7, Human

HY-P7268 50ug
EUR 639.6

NAP-2/CXCL7, Rat

HY-P7269 50ug
EUR 639.6

NAP-2, CXCL7, human

RC312-18 2ug
EUR 125.26

NAP-2, CXCL7, rat

RC352-18 2ug
EUR 125.26

Mouse beta Thromboglobulin (CXCL7/bTG) CLIA Kit

20-abx491403
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human CXCL7 Antibody (Biotin Conjugate)

32852-05121 150 ug
EUR 442.8

Human CXCL7 PicoKine ELISA Kit

EK0729 96 wells
EUR 510
Description: For quantitative detection of human CXCL7 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Human CXCL7 AssayMax ELISA Kit

EC2270-1 96 Well Plate
EUR 572.4

ELISA kit for Human CXCL7

EK5304 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human CXCL7 in samples from serum, plasma, tissue homogenates and other biological fluids.

Human CXCL7 AssayLite Antibody (FITC Conjugate)

32852-05141 150 ug
EUR 513.6

Human CXCL7 AssayLite Antibody (RPE Conjugate)

32852-05151 150 ug
EUR 513.6

Human CXCL7 AssayLite Antibody (APC Conjugate)

32852-05161 150 ug
EUR 513.6

Human CXCL7 AssayLite Antibody (PerCP Conjugate)

32852-05171 150 ug
EUR 565.2

Neutrophil Activating Protein-2 (CXCL7) Antibody

20-abx137035
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

Neutrophil Activating Protein-2 (CXCL7) Protein

20-abx261559
  • EUR 393.60
  • EUR 4101.60
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Neutrophil Activating Protein-2 (CXCL7) Protein

20-abx261561
  • EUR 393.60
  • EUR 4101.60
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Rat PPBP/CXCL7 PicoKine ELISA Kit

EK0731 96 wells
EUR 510
Description: For Quantitative Detection of rat CXCL7 in cell culture supernates, serum and plasma (heparin, EDTA).

NAP-2/CXCL7 (CHO-expressed), Human

HY-P7267 50ug
EUR 596.4

ThymusChemokine‑1/CXCL7 (CHO-expressed), Rat

HY-P7301 10ug
EUR 349.2

Nori Equine CXCL7/NAP2 ELISA Kit

GR106909 96-well
EUR 553.2

Nori® Hamster CXCL7 ELISA Kit

GR172274 96-well
EUR 553.2

Nori® Canine CXCL7 ELISA Kit

GR115398 96-well
EUR 553.2

Recombinant Human CXCL7/NAP-2 Protein

RP00829 10 μg
EUR 265.2

ELISA kit for Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)

E-EL-M1269 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)

7-02059 2µg Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)

7-02060 10µg Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7)

7-02061 1mg Ask for price

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)

7-02065 2µg Ask for price

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)

7-02066 10µg Ask for price

Recombinant Rat Neutrophil Activating Protein-2 (CXCL7)

7-02067 1mg Ask for price

Human CXCL7(Platelet basic protein) ELISA Kit

EH0007 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml

Nori® Human CXCL7-NAP2 ELISA Kit

GR106282 96-well
EUR 553.2

Human Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit

abx252283-96tests 96 tests
EUR 801.6

Neutrophil Activating Protein-2 (CXCL7), 95 a.a. Protein

20-abx260678
  • EUR 393.60
  • EUR 4101.60
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Pig Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit

abx511493-96tests 96 tests
EUR 1093.2

Rat Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit

abx255841-96tests 96 tests
EUR 801.6

Recombinant (E.Coli) Human Neutrophil Activating Protein-2 (CXCL7)

RP-1008 10 ug
EUR 343.2

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.

7-02062 2µg Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.

7-02063 10µg Ask for price

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a.

7-02064 1mg Ask for price

Human Thromboglobulin, Beta (bTG/PBP/CXCL7/NAP2) CLIA Kit

abx197774-96tests 96 tests
EUR 990

ELISA kit for Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)

E-EL-H1007 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Plasma

ELISA kit for Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta)

E-EL-R1087 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant

Human CXCL7 EZ-Set™ ELISA Kit (DIY Antibody Pairs)

EZ0729 5 plates/kit
EUR 321.6
Description: For the development of sandwich ELISA kit to measure human CXCL7 in cell culture supernates, cell lysates, tissue homogenates, serum and plasma (heparin, EDTA).

NAP-2 Neutrophil Activating Protein-2 Human Recombinant Protein (CXCL7)

PROTP02775 Regular: 10ug
EUR 380.4
Description: Neutrophil Activating Protein-2 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 70 amino acids and having a molecular mass of 7609 Dalton. ;The NAP-2 is purified by proprietary chromatographic techniques.

NAP-2 Neutrophil Activating Protein-2 Rat Recombinant Protein (CXCL7)

PROTQ99ME0 Regular: 10ug
EUR 380.4
Description: NAP-2 Rat Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 62 amino acids and having a molecular mass of 6.8kDa.;The NAP 2 is purified by proprietary chromatographic techniques.

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug

QP10212-ec-100ug 100ug
EUR 1185.6

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug

QP10212-ec-10ug 10ug
EUR 348

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug

QP10212-ec-250ug 250ug
EUR 2077.2

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug

QP10212-ec-2ug 2ug
EUR 184.8

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug

QP10285-ec-100ug 100ug
EUR 1413.6

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug

QP10285-ec-10ug 10ug
EUR 348

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug

QP10285-ec-250ug 250ug
EUR 2480.4

Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug

QP10285-ec-2ug 2ug
EUR 184.8

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-100ug

QP8641-ec-100ug 100ug
EUR 489.6

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-10ug

QP8641-ec-10ug 10ug
EUR 240

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-1mg

QP8641-ec-1mg 1mg
EUR 1958.4

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-200ug

QP8641-ec-200ug 200ug
EUR 760.8

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-500ug

QP8641-ec-500ug 500ug
EUR 1272

Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-50ug

QP8641-ec-50ug 50ug
EUR 315.6

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2

C056-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2

C056-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2

C056-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2

C056-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

NAP-2-95 Neutrophil Activating Protein-2 (CXCL7) Human Recombinant Protein, 95 a.a.

PROTP02775-1 Regular: 10ug
EUR 380.4
Description: NAP 2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 95 amino acids (35-128) and having a molecular mass of 10.3 kDa.;The NAP 2 is purified by proprietary chromatographic techniques.

Mouse anti IgA1

10-I06A 1 mg
EUR 369.6
Description: Mouse anti IgA1 antibody

UltraTek Anti-Mouse

ABJ008 8 ml
EUR 96

UltraTek Anti-Mouse

ABJ015 15 ml
EUR 117.6

UltraTek Anti-Mouse

ABJ125 125 ml
EUR 273.6

UltraTek Anti-Mouse

ABJ500 500 ml
EUR 664.8

UltraTek Anti-Mouse

ABJ999 1000 ml
EUR 1120.8

SensiTek Anti-Mouse

ABC008 8 ml
EUR 85.2

SensiTek Anti-Mouse

ABC015 15 ml
EUR 96

SensiTek Anti-Mouse

ABC125 125 ml
EUR 211.2

SensiTek Anti-Mouse

ABC500 500 ml
EUR 504

SensiTek Anti-Mouse

ABC999 1000 ml
EUR 853.2

anti-mouse VLK

AR03-PA0002 100 ul
EUR 400.8
Description: Rabbit polyclonal to VLK

Mouse Anti-FcεRIα

MOFCeRIaAP(V100) 100 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaAP(V25) 25 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaB(V100) 100 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaB(V25) 25 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaCFB(V100) 100 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaCFB(V25) 25 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaF(V100) 100 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaF(V25) 25 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaF(V500) 500 ug
EUR 60

Mouse Anti-FcεRIα

MOFCeRIaPE(V100) 100 ug
EUR 60

Leave a Reply

Your email address will not be published. Required fields are marked *